OPRX OPTIMIZERx Corp
Company Analysis
Latest News
OptimizeRx Corp Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
OptimizeRx Corp is projected to report Q2 2026 revenue of $28.45 million and an EPS of $0.01, with the current stock price of $12.45 trading at a significant...
🟢 OPTIMIZERx is trading 5.3% up today as software and AI stocks rally
OPTIMIZERx is trading 5.3% up today at $6.90 as shares rise alongside a broader rally in software and AI-related stocks. • The move continues a rebound...
🟢 OPTIMIZERx is trading 5.8% up today on a technical rebound amid broader market strength
OPTIMIZERx is trading 5.8% up at $6.40, rebounding from a 5.1% idiosyncratic drop during the previous session. • The move appears to be a technical bounce...
🟢 OPTIMIZERx is trading 5.8% up today as it rebounds from recent weakness
OPTIMIZERx is trading 5.8% up at $6.40 in pre-market, rebounding from the previous session’s idiosyncratic 5.1% drop. • The recovery comes despite a lack of...
🔴 OPTIMIZERx is trading 5.1% down today amid idiosyncratic weakness and no clear catalyst
OPTIMIZERx is trading at $5.95 (-5.10%) following a sharp selloff with no clear company-specific catalyst identified in recent news. • The move appears...
🔴 OPRX is trading 5.1% down today on downward earnings revisions and cautious analyst sentiment
OPRX is trading at $5.97 (down 5.1%) as the stock extends a recent decline driven by weaker growth expectations and cautious analyst outlooks. • Recent...
🟢 OPRX is trading 5.3% up today on continued AI-product optimism and analyst support
OPRX is trading 5.3% up now at $6.40 as its recent AI-driven product launch and supportive analyst commentary continue to attract investor interest. The stock...
🟢 OPRX surges 14.6% on AI product launch excitement and analyst support
OPRX is trading at $6.97 (14.6% up) in after-hours trading, extending a multi-session rally. Renewed optimism surrounds the company’s AI product strategy,...
🟢 OPRX is trading 5.2% up today as AI strategy optimism and analyst support fuel rally
OPRX is trading 5.2% up at $5.71 as the stock extends a multi-session rally driven by renewed optimism around its AI product strategy and supportive analyst...
🟢 OPRX is trading 5.1% up today on bullish analyst commentary and AI tool launch
OPRX is trading 5.1% up at $5.38 after bullish analyst commentary and an AI product launch reignited interest in the stock. • Citizens recently reiterated its...
🟢 OPRX is trading 5.1% up today after Citizens reiterated its $9 target and a new AI tool launch
OPRX is trading 5.1% up at $5.15 after Citizens reiterated its bullish rating and the company launched a new AI-powered tool for pharma marketers. • Citizens...
OptimizeRx Gets a Bullish Nod and a New AI Tool — But Can Product Launches Overcome a Shrinking Revenue Base?
Shares of OptimizeRx surged 13.9% in after-hours trading to $5.58 on June 25 after a one-two punch: a reiterated Market Outperform rating from Citizens with a...
🟢 OPRX is trading 13.9% up today after AI tool launch and bullish analyst coverage
OPRX is trading 13.9% up in after-hours trading at $5.58 following the launch of a new AI-powered tool and positive analyst sentiment. • Citizens reiterated a...
🟢 OPRX is trading 5.1% up today after upbeat analyst commentary and new AI product launch
• Citizens reiterated its Market Outperform rating on the stock with a $9.00 price target, suggesting significant potential upside from current levels. • The...
🔴 OPTIMIZERx Corp is trading 5% down today amid technical weakness and a cautious 2026 outlook
OPTIMIZERx Corp is trading at $4.73 (down 5%) amid ongoing technical weakness and a lack of fresh market catalysts. • The decline appears to be a continuation...
OPRX Shareholders Approve 1 Million Share Increase to 2021 Equity Incentive Plan
OptimizeRx Corporation announced that shareholders approved an amendment to its 2021 Equity Incentive Plan at the Annual Meeting on June 9, 2026. The amendment...
OptimizerRx price target falls 20%, following persistent credibility concerns
Analysts lowered the average one-year price target for OptimizerRx to $11.73 per share. This revision represents a 20.69% decrease from the previous estimate...
🟢 OPTIMIZERx Corp is trading 5.2% up today as a volatility bounce after recent weakness
OPTIMIZERx Corp is trading 5.2% up at $5.31 today as a volatility bounce after recent weakness, with no clear company-specific catalyst identified. • No fresh...
OptimizeRx Announces Departure of Chief Commercial Officer Theresa Greco
OptimizeRx Corporation disclosed the departure of its Chief Commercial Officer, Theresa Greco, effective June 15, 2026. The company entered into a Separation...
🔴 OPTIMIZERx Corp is trading 5.2% down today as it retreats from recent gains amid broader tech weakness
OPTIMIZERx Corp is trading at $5.10 (5.2% down) as the stock pulls back from a recent rally following its appearance at the 46th Annual William Blair Growth...